global biosimilars/follow-on-biologics market (technology, types, applications, services and...
DESCRIPTION
Market Research Reports, Inc. has announced the addition of “Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020” research report to their offering. See more at- http://mrr.cm/Z7XTRANSCRIPT
www.MarketResearchReports.com
Global Biosimilars/Follow-on-
Biologics Market (Technology, Types,
Applications, Services and Geography), Opportunities,
Segmentation and Forecast, 2013 - 2020
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: July 1, 2014
Number of Pages: 184
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 4,515
Price For Site User License: USD 7,515
Price For Global User License: USD 10,515
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
"Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013.
Deeper penetration with clearer regulatory pathways in developed markets and higher efficacy & safety in emerging markets will back the market growth during the forecast period.
www.MarketResearchReports.com
Research Findings
Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020.
Regulations for biosimilars plays a vital role in maintaining the viability and balance between original and biosimilar products. Various regulatory authorities, namely EMA and the U.S. FDA are actively regulating the biosimilars market.
Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, the European market has been maximizing on the biosimilars market.
Europe was the first region to draft guidelines for approval of biosimilars in 2006. Nevertheless, in 2008, the first biosimilars version of Granulocyte colony-stimulating factor (G-CSF) was introduced in the European Union under the regulatory guidance of European Medical Association (EMA).
www.MarketResearchReports.com
Key Benefits
The study is segmented in a strategic divisions to gain deeper insights into the market dynamics and understand the competitive environment of the overall market
Financial market forecast is provided for the next eight years by considering 2013 as the base year
Comprehensive and quantitative data about changing market trends, intensifying competition and opportunities in biosimilars market are provided to make better business decisions
www.MarketResearchReports.com
Key Benefits Continues…
Porter’s Five Forces model and SWOT analysis of the overall market is provided to help stakeholders gain strategic insights of the market
Deep dive analysis of key market players and strategies adopted by them are expounded to provide valuable information on the top contenders in the market
Identification of key investment pockets for the biosimilars market is strategically dealt to assist the stakeholders
www.MarketResearchReports.com
Segments Covered
Market By Technology
Market By Types
Market By Applications
Market By Services
Market By Geography
www.MarketResearchReports.com
Report Coverage
1. Introduction2. Executive Summary3. Market Overview4. Global Biosimilars/Follo-on-biologics Market By
Technology5. Global Biosimilars/Follow-on-biologics Market By
Product Type6. Global Biosimilars/Follow-on-biologics Market By
Applications7. Global Biosimilars / Follow-on-biologics Market By
Services8. Global Biosimilars/Follow-on-biologics Market By
Geographies9. Key Products And Recent Activities By Geography10.Company Profiles
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Company Coverage
1. Novartis (Sandoz)
2. Synthon Pharmaceuticals, Inc.
3. Teva Pharmaceutical Industries Ltd.
4. LG Life Sciences
5. Celltrion
6. Biocon
7. Hospira
8. Merck Serono (Merck Group)
9. Biogen idec Inc.
10.Genentech (Roche Group).
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/Z7X
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)